| Chemistry | Lifetime | 319 | US 132 | 99.77 |
| Biochemistry | Lifetime | 6 | US 3 | 99.87 |
| Organic Chemistry | Lifetime | 137 | US 60 | 99.77 |
| Pharmacology | Lifetime | 156 | US 75 | 98.68 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 823 | US 430 | 96.99 |
| Chemical Synthesis and Catalysis | Lifetime | 783 | US 194 | 93.34 |
| Pharmaceutical Science | Lifetime | 978 | US 279 | 67.52 |
| Biochemistry | 2021-2025 | 70 | US 17 | 88.38 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 11 | US 7 | 99.83 |
| Hormonal Regulation and Hypertension | Lifetime | 29 | US 14 | 99.68 |
| Pharmacogenetics and Drug Metabolism | Lifetime | 34 | US 21 | 99.60 |
| Chemical Synthesis and Reactions | Lifetime | 96 | US 22 | 99.47 |
| Nitric Oxide and Endothelin Effects | Lifetime | 95 | US 45 | 99.49 |
| Inflammatory mediators and NSAID effects | Lifetime | 158 | US 83 | 98.78 |
| Carbohydrate Chemistry and Synthesis | Lifetime | 203 | US 85 | 98.88 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 547 | US 262 | 98.53 |
| Sulfur-Based Synthesis Techniques | Lifetime | 159 | US 27 | 98.70 |
| Synthesis and Catalytic Reactions | Lifetime | 218 | US 59 | 98.68 |
| Diet, Metabolism, and Disease | Lifetime | 357 | US 138 | 98.14 |
| Synthetic Organic Chemistry Methods | Lifetime | 511 | US 151 | 98.55 |
| Catalytic Cross-Coupling Reactions | Lifetime | 272 | US 56 | 98.57 |
| Chemical synthesis and alkaloids | Lifetime | 273 | US 105 | 97.80 |
| Chemical Synthesis and Analysis | Lifetime | 949 | US 297 | 98.01 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 382 | US 187 | 97.35 |
| Catalytic C–H Functionalization Methods | Lifetime | 483 | US 75 | 98.35 |
| Asymmetric Synthesis and Catalysis | Lifetime | 637 | US 163 | 98.14 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 741 | US 289 | 96.80 |
| Asymmetric Hydrogenation and Catalysis | Lifetime | 688 | US 152 | 97.74 |
| Alcohol Consumption and Health Effects | Lifetime | 736 | US 345 | 95.41 |
| Cyclopropane Reaction Mechanisms | Lifetime | 713 | US 166 | 96.09 |
| Free Radicals and Antioxidants | Lifetime | 812 | US 243 | 95.45 |
| Organic Chemistry Cycloaddition Reactions | Lifetime | 754 | US 217 | 95.40 |
| Synthesis and Reactions of Organic Compounds | Lifetime | 983 | US 214 | 94.64 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 800 | US 409 | 95.15 |
| Coordination Chemistry and Organometallics | Lifetime | 642 | US 153 | 95.45 |
| Natural Product Synthesis and Anticancer Bioactivity | Lifetime | 456 | US 95 | 90.51 |
| Synthesis and Reactivity of Heterocycles | Lifetime | 854 | US 129 | 89.31 |
| Advanced Synthetic Organic Chemistry | Lifetime | 804 | US 194 | 86.92 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 61 | US 30 | 90.14 |
| Hormonal Regulation and Hypertension | 2021-2025 | 841 | US 179 | 80.92 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 484 | US 110 | 66.82 |